Rockwell Medical Inc. announced that its Board of Directors has appointed Stuart Paul as Chief Executive Officer of the Company, effective September 4, 2018. Mr. Paul will also join the Rockwell Medical Board of Directors at that time.
"Having served in senior leadership roles with Baxter International, Gambro AB, Quest Diagnostics and Abbott Laboratories throughout his 25-year career, Stuart has substantial experience in the health care industry, including the renal space,“ Ben Wolin, Chairman of the Rockwell Medical Board, said in a press release. “He is a well-rounded executive who not only brings significant operating expertise and commercialization know-how across both domestic and international markets, but he is also deeply familiar with the clinical development process. Stuart's successful track record of executing on commercialization strategies and driving growth and profitability will be critical to Rockwell Medical as we move forward."
"I am thrilled to be joining Rockwell Medical and look forward to hitting the ground running as CEO,” Paul said in the press release. “I am excited by the prospect of working alongside the Board, management and Rockwell Medical's employees to accelerate the Company's growth and realize the full potential of Triferic and Calcitriol.”
Ignite Search Partners, a leading executive recruiting firm, assisted the Board of Directors during the search process.